930
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluation

Guselkumab for the treatment of palmoplantar pustulosis

ORCID Icon
Pages 841-852 | Received 30 Nov 2019, Accepted 21 Apr 2020, Published online: 12 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kristine Heidemeyer, Marco May Lee, Simone Cazzaniga, Nikhil Yawalkar & Luigi Naldi. (2023) Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies. Psoriasis: Targets and Therapy 13, pages 33-58.
Read now

Articles from other publishers (8)

Daniela Anghel, Mihaela Georgescu, Marcela Poenaru, Diana Maria Orleanu & George Sorin Tiplica. (2023) Paradoxical pustular psoriasis in a patient with spondyloarthritis treated with secukinumab. JEADV Clinical Practice 2:4, pages 951-954.
Crossref
Thierry Passeron, Jose Manuel Carrascosa, Richard B. Warren, Andreas Pinter, Marco Romanelli, Patricia Gorecki, Michela Efficace, Steve Fakharzadeh, Ya-Wen Yang, Ahlem Azzabi, Maria Jazra, Katya Lemos, Monica Leung, Yanqing Chen & Diamant Thaçi. (2023) A Phase IIIb, Multicentre, Interventional, Randomised, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G-PLUS). Dermatologic Therapy 2023, pages 1-14.
Crossref
Jang Hwan Jung, Sun Mun Jeong, Do Ik Kwon, Seol Hwa Seong, Joon Hee Kim, Jong Bin Park, Kee Suck Suh & Min Soo Jang. (2023) Successful Treatment of Recalcitrant Palmoplantar Pustulosis with Guselkumab. Annals of Dermatology 35.
Crossref
F. Assan, B. Husson, S. Hegazy, J. Seneschal, F. Aubin, E. Mahé, D. Jullien, E. Sbidian, M. D'Incan, C. Conrad, E. Brenaut, C. Girard, M.A. Richard, H. Bachelez & M. Viguier. (2022) Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort. Journal of the European Academy of Dermatology and Venereology 36:9, pages 1578-1583.
Crossref
Yuki Iwaki, Sayori Shibata & Chuanpu Hu. (2021) Pharmacokinetic/Pharmacodynamic Analysis of Guselkumab for Treatment of Palmoplantar Pustulosis: Clinical Implications of Guselkumab Dose, Disease Severity, and Smoking in Japanese Patients. The Journal of Clinical Pharmacology 62:2, pages 182-189.
Crossref
N. Hlaca, T. Zagar, M. Kastelan, I. Brajac & L. Prpic‐Massari. (2021) Ixekizumab‐induced paradoxical pustular reaction successfully treated with guselkumab. Clinical and Experimental Dermatology 46:8, pages 1572-1573.
Crossref
Yukari Okubo, Hitomi Morishima, Richuan Zheng & Tadashi Terui. (2021) Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study. The Journal of Dermatology 48:12, pages 1838-1853.
Crossref
Yurie Akiyama, Masaki Minabe, Junichiro Inada, Takeshi Nomura, Shinichi Takahashi, Kazuyuki Ishihara & Michiyoshi Kouno. (2021) The oral microbial composition and diversity affect the clinical course of palmoplantar pustulosis patients after dental focal infection treatment. Journal of Dermatological Science 104:3, pages 193-200.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.